These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

107 related items for PubMed ID: 21674798

  • 1. Differential expression of intermediate filaments in the process of developing hepatic steatosis.
    Park JE, Kim HT, Lee S, Lee YS, Choi UK, Kang JH, Choi SY, Kang TC, Choi MS, Kwon OS.
    Proteomics; 2011 Jul; 11(14):2777-89. PubMed ID: 21674798
    [Abstract] [Full Text] [Related]

  • 2. Hepatic gene expression profiles in a long-term high-fat diet-induced obesity mouse model.
    Kim S, Sohn I, Ahn JI, Lee KH, Lee YS, Lee YS.
    Gene; 2004 Sep 29; 340(1):99-109. PubMed ID: 15556298
    [Abstract] [Full Text] [Related]

  • 3. Long-term adaptation of global transcription and metabolism in the liver of high-fat diet-fed C57BL/6J mice.
    Do GM, Oh HY, Kwon EY, Cho YY, Shin SK, Park HJ, Jeon SM, Kim E, Hur CG, Park TS, Sung MK, McGregor RA, Choi MS.
    Mol Nutr Food Res; 2011 Sep 29; 55 Suppl 2():S173-85. PubMed ID: 21618427
    [Abstract] [Full Text] [Related]

  • 4. Effect of exercise on hepatic gene expression in an obese mouse model using cDNA microarrays.
    Lee KY, Kim SJ, Cha YS, So JR, Park JS, Kang KS, Chon TW.
    Obesity (Silver Spring); 2006 Aug 29; 14(8):1294-302. PubMed ID: 16988071
    [Abstract] [Full Text] [Related]

  • 5. Oleuropein attenuates hepatic steatosis induced by high-fat diet in mice.
    Park S, Choi Y, Um SJ, Yoon SK, Park T.
    J Hepatol; 2011 May 29; 54(5):984-93. PubMed ID: 21145829
    [Abstract] [Full Text] [Related]

  • 6. Increased expression of PPARgamma in high fat diet-induced liver steatosis in mice.
    Inoue M, Ohtake T, Motomura W, Takahashi N, Hosoki Y, Miyoshi S, Suzuki Y, Saito H, Kohgo Y, Okumura T.
    Biochem Biophys Res Commun; 2005 Oct 14; 336(1):215-22. PubMed ID: 16125673
    [Abstract] [Full Text] [Related]

  • 7. The inhibitory effect of genistein on hepatic steatosis is linked to visceral adipocyte metabolism in mice with diet-induced non-alcoholic fatty liver disease.
    Kim MH, Kang KS, Lee YS.
    Br J Nutr; 2010 Nov 14; 104(9):1333-42. PubMed ID: 20687969
    [Abstract] [Full Text] [Related]

  • 8. Gene expression in livers of BALB/C and C57BL/6J mice fed a high-fat diet.
    Nishikawa S, Sugimoto J, Okada M, Sakairi T, Takagi S.
    Toxicol Pathol; 2012 Nov 14; 40(1):71-82. PubMed ID: 22105644
    [Abstract] [Full Text] [Related]

  • 9. Sequential responses to high-fat and high-calorie feeding in an obese mouse model.
    Chan MY, Zhao Y, Heng CK.
    Obesity (Silver Spring); 2008 May 14; 16(5):972-8. PubMed ID: 18292748
    [Abstract] [Full Text] [Related]

  • 10. The immunosuppressant drug, thalidomide, improves hepatic alterations induced by a high-fat diet in mice.
    Pinto Lde F, Compri CM, Fornari JV, Bartchewsky W, Cintra DE, Trevisan M, Carvalho Pde O, Ribeiro ML, Velloso LA, Saad MJ, Pedrazzoli J, Gambero A.
    Liver Int; 2010 Apr 14; 30(4):603-10. PubMed ID: 20088867
    [Abstract] [Full Text] [Related]

  • 11. Ezetimibe decreases SREBP-1c expression in liver and reverses hepatic insulin resistance in mice fed a high-fat diet.
    Muraoka T, Aoki K, Iwasaki T, Shinoda K, Nakamura A, Aburatani H, Mori S, Tokuyama K, Kubota N, Kadowaki T, Terauchi Y.
    Metabolism; 2011 May 14; 60(5):617-28. PubMed ID: 20673929
    [Abstract] [Full Text] [Related]

  • 12. Rose hip exerts antidiabetic effects via a mechanism involving downregulation of the hepatic lipogenic program.
    Andersson U, Henriksson E, Ström K, Alenfall J, Göransson O, Holm C.
    Am J Physiol Endocrinol Metab; 2011 Jan 14; 300(1):E111-21. PubMed ID: 20959531
    [Abstract] [Full Text] [Related]

  • 13. Ezetimibe improves high fat and cholesterol diet-induced non-alcoholic fatty liver disease in mice.
    Zheng S, Hoos L, Cook J, Tetzloff G, Davis H, van Heek M, Hwa JJ.
    Eur J Pharmacol; 2008 Apr 14; 584(1):118-24. PubMed ID: 18329014
    [Abstract] [Full Text] [Related]

  • 14. Identification of early proteomic markers for hepatic steatosis.
    Meneses-Lorente G, Watt A, Salim K, Gaskell SJ, Muniappa N, Lawrence J, Guest PC.
    Chem Res Toxicol; 2006 Aug 14; 19(8):986-98. PubMed ID: 16918237
    [Abstract] [Full Text] [Related]

  • 15. Antisense oligonucleotide reduction of DGAT2 expression improves hepatic steatosis and hyperlipidemia in obese mice.
    Yu XX, Murray SF, Pandey SK, Booten SL, Bao D, Song XZ, Kelly S, Chen S, McKay R, Monia BP, Bhanot S.
    Hepatology; 2005 Aug 14; 42(2):362-71. PubMed ID: 16001399
    [Abstract] [Full Text] [Related]

  • 16. Functional proteomic analysis of nonalcoholic fatty liver disease in rat models: enoyl-coenzyme a hydratase down-regulation exacerbates hepatic steatosis.
    Zhang X, Yang J, Guo Y, Ye H, Yu C, Xu C, Xu L, Wu S, Sun W, Wei H, Gao X, Zhu Y, Qian X, Jiang Y, Li Y, He F.
    Hepatology; 2010 Apr 14; 51(4):1190-9. PubMed ID: 20162621
    [Abstract] [Full Text] [Related]

  • 17. Altered expression of transcription factors and genes regulating lipogenesis in liver and adipose tissue of mice with high fat diet-induced obesity and nonalcoholic fatty liver disease.
    Morgan K, Uyuni A, Nandgiri G, Mao L, Castaneda L, Kathirvel E, French SW, Morgan TR.
    Eur J Gastroenterol Hepatol; 2008 Sep 14; 20(9):843-54. PubMed ID: 18794597
    [Abstract] [Full Text] [Related]

  • 18. Lipoic acid prevents high-fat diet-induced dyslipidemia and oxidative stress: a microarray analysis.
    Yang RL, Li W, Shi YH, Le GW.
    Nutrition; 2008 Jun 14; 24(6):582-8. PubMed ID: 18367378
    [Abstract] [Full Text] [Related]

  • 19. ERp57 is up-regulated in free fatty acids-induced steatotic L-02 cells and human nonalcoholic fatty livers.
    Wang H, Chan PK, Pan SY, Kwon KH, Ye Y, Chu JH, Fong WF, Tsui WM, Yu ZL.
    J Cell Biochem; 2010 Aug 15; 110(6):1447-56. PubMed ID: 20506389
    [Abstract] [Full Text] [Related]

  • 20. Impairment of fat oxidation under high- vs. low-glycemic index diet occurs before the development of an obese phenotype.
    Isken F, Klaus S, Petzke KJ, Loddenkemper C, Pfeiffer AF, Weickert MO.
    Am J Physiol Endocrinol Metab; 2010 Feb 15; 298(2):E287-95. PubMed ID: 19934403
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.